Back to Journals » OncoTargets and Therapy » Volume 7

Retreatment with bevacizumab in patients with gynecologic malignancy is associated with clinical response and does not increase morbidity

Total article views   HTML views PDF downloads Totals
8,974 Dovepress* 8,037+ 1,341 9,378
PubMed Central* 937 328 1,265
Totals 8,974 1,669 10,643
*Since 21 March 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar